LadRx (LADX, $1.5) was a top loser over the last three months, falling -2 to $1.5 per share. A.I.dvisor analyzed 831 stocks in the Biotechnology Industry for the 3-month period ending June 13, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.